Bone Features of Unaffected Skeletal Sites in Melorheostosis: A Case Report

Kotwal, 2017, Melorheostosis: a rare sclerosing bone dysplasia, Curr Osteoporos Rep, 15, 335, 10.1007/s11914-017-0375-y Boulet, 2016, Sclerosing bone dysplasias: genetic, clinical and radiology update of hereditary and non-hereditary disorders, Br J Radiol, 89, 10.1259/bjr.20150349 Gregson, 2013, Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management, Rheumatology (Oxford), 52, 968, 10.1093/rheumatology/ket007 Jha, 2018, Distinct clinical and pathological features of melorheostosis associated with somatic MAP2K1 mutations, J Bone Miner Res, 34, 145, 10.1002/jbmr.3577 Kanis, 1994, The diagnosis of osteoporosis, J Bone Miner Res, 9, 1137, 10.1002/jbmr.5650090802 ACR–SPR–SSRPractice Parameter For The Performance Of Musculoskeletal Quantitative Computed Tomography (Qct). Revised 2018. Available at: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/QCT.pdf. Accessed August 12, 2019. Anderson, 2019, Reference ranges for trabecular bone score in Australian men and women: a cross-sectional study, JBMR Plus, 3, e10133, 10.1002/jbm4.10133 Smith, 2017, Melorheostosis: a retrospective clinical analysis of 24 patients at the Mayo Clinic, PM R, 9, 283, 10.1016/j.pmrj.2016.07.530 Kang, 2018, Somatic activating mutations in MAP2K1 cause melorheostosis, Nat Commun, 9, 1390, 10.1038/s41467-018-03720-z Whyte, 2017, Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS, Bone, 101, 145, 10.1016/j.bone.2017.04.010 Li, 2013, Comparison of QCT and DXA: osteoporosis detection rates in postmenopausal women, Int J Endocrinol, 2013, 10.1155/2013/895474 Whyte, 2005, Misinterpretation of osteodensitometry with high bone density: BMD Z >or = + 2.5 is not ‘normal’, J Clin Densitom, 8, 1, 10.1385/JCD:8:1:001 Gregson, 2012, ‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass, Osteoporos Int, 23, 643, 10.1007/s00198-011-1603-4 Slimani, 2013, Successful treatment of pain in melorheostosis with zoledronate, with improvement on bone scintigraphy, BMJ Case Rep, 10.1136/bcr-2013-009820 Byberg, 2018, Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case report, J Med Case Rep, 12, 278, 10.1186/s13256-018-1820-y Donáth, 2002, Atypical form of active melorheostosis and its treatment with bisphosphonate, Skeletal Radiol, 31, 709, 10.1007/s00256-002-0576-y Hollick, 2010, Melorheostosis and its treatment with intravenous zoledronic acid, BMJ Case Rep, 10.1136/bcr.04.2009.1757